|
Class 2 Device Recall Oxoid CM0225 Brain Heart Infusion IVD |
|
Date Initiated by Firm |
December 21, 2009 |
Date Posted |
March 09, 2010 |
Recall Status1 |
Terminated 3 on July 12, 2011 |
Recall Number |
Z-0979-2010 |
Recall Event ID |
54194 |
Product Classification |
Brain Heart Infusion IVD - Product Code JSC
|
Product |
Oxoid CM0225 Brain Heart Infusion IVD. The firm name on the label is Oxoid Ltd., Basingstoke, Hampshire, England.
The product is used for the cultivation of streptococci, pneumococci, meningococci and other fastidious organisms and is suitable for blood culture work. |
Code Information |
Lot numbers 762134, Exp. 2014.04.30; 793640, Exp. 2014.07.31; and 819693, Exp. 2014.10.31 |
Recalling Firm/ Manufacturer |
Remel, Inc 12076 Santa Fe Trail Dr Lenexa KS 66215-3519
|
For Additional Information Contact |
Debbie Wyatt 913-895-4075
|
Manufacturer Reason for Recall |
Product failure - Failure to grow quality control strains of Streptococcus pneumoniae.
|
FDA Determined Cause 2 |
Other |
Action |
The recalling firm issued separate recall letters dated December 21, 2009 addressed to Microbiology Laboratory Supervisors or Distributors explaining the reason for recall and requesting all remaining product be discarded. A Product Inventory Checklist was enclosed to report the amount of product that was discarded by the customer. The Distributor letter requests the consignee contact their customers to notify them of the recall. Direct inquiries concerning this recall to the Technical Services Department at 1-800-255-6730 (United States) or 1-913-888-0939 (International). |
Quantity in Commerce |
105 bottles |
Distribution |
United States (FL, NY, MO, NY, DE, and PA). |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|